Viral Respiratory Infection including COVID-19: From Molecular Mechanisms to Therapies Strategies
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 856
Special Issue Editors
Interests: clinical pharmacology; infectious diseases; antimicrobial agents
Special Issues, Collections and Topics in MDPI journals
Interests: cancer; antibiotic; treatement
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The background of this issue stems from the global pandemic caused by the SARS-CoV-2 virus, which has led to an urgent need for effective therapies to treat not only COVID-19 but other viral respiratory infections as well. These infections continue to pose significant threats to global health and economies, highlighting the importance of this special issue. The primary goal of this special issue is to provide a comprehensive platform for researchers worldwide to share their latest findings, insights, and advancements in identifying and validating therapeutic targets for viral respiratory infections. This includes the development and evaluation of novel drugs, antibodies, and vaccines. Ultimately, the insights gained from this special issue will contribute to the global efforts in combating viral respiratory infections and reducing their impact on society.
Prof. Dr. Francesco Scaglione
Dr. Arianna Pani
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- post-COVID
- syndrome
- COVID-19
- viral respiratory infections
- SARS-CoV-2
